The Zhitong Finance App learned that CICC published a research report on Yidu Technology (02158) for the first time and gave the company a “outperform the industry” rating. The company is a leading provider of medical intelligence solutions, empowering the medical industry with big data and artificial intelligence. The bank is optimistic about the industry insight and customer resources the company has accumulated through its mature big data platform business, and believes that it is expected to continue to develop diverse monetization spaces.
According to the report, the company has built the three major business segments of big data platforms and solutions, life science solutions, and health management platforms and solutions, with the self-developed data intelligence infrastructure YiduCore as the core. The customers it serves cover various participants in the medical market, such as regulators, hospitals, pharmaceutical companies, insurance companies, doctors and patients, and focuses on solving key pain points in the three major medical scenarios of public health, research, diagnosis and treatment. According to Frost&Sullivan's statistics, Medu Technology ranked first in the emerging medical intelligence market in 2021, with a market share of 25.6%.
The bank believes that, driven by favorable policies and customer needs, China's medical industry is moving from informatization to intelligence. Medical intelligence is supported by cutting-edge technologies such as big data and artificial intelligence, integrates multi-source data inside and outside hospitals, continuously accumulates algorithm models and industry insights from the analysis of large amounts of data, and empowers participants in various industries to make intelligent and efficient decisions. According to Frost&Sullivan's forecast, the compound annual growth rate of China's medical intelligence market is expected to be 41.4% in 2022-2027. With solid product capabilities, deep customer relationships and diverse monetization channels, the bank believes that emerging medical intelligence companies are continuing to gain market share.
CICC said that the network effects and scale advantages of Yidu Technology are gradually taking shape. Yidu Technology has achieved coverage of a certain scale of customer groups, especially hospital customers, and has a wide range of doctor and medical expert resources, and medical data is an important foundation for medical intelligence. Based on extensive data access and strong technical capabilities, Yidu Technology has been able to accumulate large-scale medical insights and gradually develop an advantage of scale. The bank believes it is expected to open up diversified monetization space. Looking ahead, the company plans to focus strategically, promote collaboration among various business segments, and continue to strengthen its position and competitiveness in the industry.
The Zhitong Finance App also learned that recently, Yidu Technology has won a number of major orders in a row. Among them, Ningbo Century Kangtai Insurance Brokers Co., Ltd., an affiliate of Yidu Technology, won the bid for the third party platform project for the Shenzhen Huimin Insurance Project as the lead unit of the consortium. Up to now, Yidu Technology has won the bid to participate in the development and operation of welfare insurance projects in 12 cities in 4 provinces including Jiangsu, Beijing, Tianjin, and Shenzhen, using intelligent technology to help build a multi-level medical insurance system.